Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
- 3 December 2007
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 198 (1), 65-76
- https://doi.org/10.1016/j.atherosclerosis.2007.10.003
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitusPharmacological Research, 2007
- Uncoupling of Endothelial Nitric Oxidase Synthase by Hypochlorous AcidArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Tetrahydrobiopterin and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Endothelial Nitric Oxide Synthase in Vascular DiseaseCell Metabolism, 2006
- Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cellsCardiovascular Research, 2006
- Dysregulation of the endothelial nitric oxide synthase–soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic ratAtherosclerosis, 2005
- The effect of high glucose on NO and O2− through endothelial GTPCH1 and NADPH oxidaseLife Sciences, 2004
- Atorvastatin Prevents End-Organ Injury in Salt-Sensitive HypertensionHypertension, 2004
- HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen SpeciesHypertension, 2001
- Validation of Lucigenin as a Chemiluminescent Probe to Monitor Vascular Superoxide as Well as Basal Vascular Nitric Oxide ProductionBiochemical and Biophysical Research Communications, 1999